As of the end of April, Taiji Pharmaceutical (03347.HK) has repurchased a total of 9.8063 million A shares.

Zhitong Finance and Economics APP News, Tiger Medicine (03347.HK) announced that as of April 30, 2025, the company's share repurchase special securities account had repurchased a total of 9.8063 million shares of the company through centralized competitive bidding trading, accounting for 1.1337% of the total share capital of the company and 1.3219% of the total A-share capital of the company. The highest transaction price was 62.00 yuan/share, the lowest transaction price was 48.17 yuan/share, and the total transaction amount was 500 million yuan (excluding transaction costs).